BBHC
CTSO icon

Brown Brothers Harriman & Co’s Cytosorbents Corp CTSO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-601
Closed -$1K – 1302
2022
Q3 		$1K Buy
+601
New +$1.17K ﹤0.01% 1457

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Brown Brothers Harriman & Co's CTSO Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Cytosorbents Corp (CTSO) in Q4 2022, closing a stake of 601 shares — an estimated $1K sold.

Brown Brothers Harriman & Co first reported a position in CTSO in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 53 funds tracked by Wall St. Rank hold CTSO as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Cytosorbents Corp position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 601 Cytosorbents Corp shares in Q4 2022, an estimated $1K.
  • Brown Brothers Harriman & Co first reported a position in Cytosorbents Corp in Q3 2022 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Cytosorbents Corp position peaked at $1K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.